Home/Filings/4/0002048634-25-000004
4//SEC Filing

Brackmann Christoph 4

Accession 0002048634-25-000004

CIK 0001645113other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 4:10 PM ET

Size

5.3 KB

Accession

0002048634-25-000004

Insider Transaction Report

Form 4
Period: 2025-11-04
Brackmann Christoph
Chief Financial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2025-11-04$12.23/sh7,033$86,014134,117 total
Footnotes (1)
  • [F1]Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0002048634

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:10 PM ET
Size
5.3 KB